KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 112 filers reported holding KYMERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,490,409 | +603.5% | 99,776 | +512.8% | 0.02% | +650.0% |
| Q3 2022 | $354,000 | -55.4% | 16,282 | -59.6% | 0.00% | -60.0% |
| Q2 2022 | $793,000 | +33.7% | 40,292 | +187.5% | 0.01% | 0.0% |
| Q1 2022 | $593,000 | -59.5% | 14,017 | -43.8% | 0.01% | -72.2% |
| Q3 2021 | $1,466,000 | +114.6% | 24,962 | +77.3% | 0.02% | +125.0% |
| Q2 2021 | $683,000 | -29.4% | 14,079 | -43.5% | 0.01% | -33.3% |
| Q1 2021 | $968,000 | – | 24,917 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |